NEW YORK, July 9, 2026 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor conferences in July:July 14-15: Leerink Partners Therapeutics Forum. Erik…
News provided by PR Newswire.
